Vai al contenuto principale della pagina
| Autore: |
DuCros Philipp
|
| Titolo: |
Innovation and Evidence for Achieving TB Elimination in the Asia-Pacific Region
|
| Pubblicazione: | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica: | 1 online resource (238 p.) |
| Soggetto topico: | Humanities |
| Social interaction | |
| Soggetto non controllato: | active case finding |
| active TB case-finding | |
| adverse drug reactions | |
| Asia Pacific | |
| Bangladesh regimen | |
| bone TB | |
| case detection | |
| chest X-ray | |
| community health workers | |
| community outreach | |
| contact investigation | |
| contact tracing | |
| contacts | |
| diabetes mellitus | |
| diagnostic algorithm | |
| End TB | |
| extrapulmonary tuberculosis | |
| health promotion | |
| household contact | |
| household contacts tracing | |
| incidence | |
| indigenous population | |
| Indonesia | |
| innovation | |
| intermediary agency | |
| key population | |
| laboratory methods | |
| latent TB infection | |
| lymph node TB | |
| MDR-TB | |
| missing cases | |
| mobile X-ray screening | |
| multidrug-resistant tuberculosis | |
| n/a | |
| national TB program | |
| notification | |
| operational research | |
| operations research | |
| pediatric TB | |
| post-tuberculosis morbidity and mortality | |
| private sector | |
| public-private mix model | |
| public-private partnership | |
| referral | |
| resources | |
| rifapentine-isoniazid | |
| screening | |
| socio-economic determinants | |
| SORT IT | |
| South-East Asia | |
| sputum | |
| STR | |
| sustainable development goals | |
| TB | |
| TB diagnosis | |
| TB diagnostics | |
| TB elimination | |
| TB preventive therapy | |
| TB REACH | |
| TB-DM | |
| tuberculosis | |
| unfavourable outcome | |
| verbal screening | |
| Viet Nam | |
| Western Pacific Region | |
| Xpert Ultra | |
| yield | |
| Persona (resp. second.): | HussainHamidah |
| VineyKerri | |
| DuCrosPhilipp | |
| Sommario/riassunto: | The World Health Organization's (WHO) END-TB strategy has set the world on course to climb the highest of medical mountains by 2035, with a targeted peak of reductions in TB deaths by 95%, TB cases by 90%, and no burdens of catastrophic expenses on families due to TB. Eliminating TB in the Asia-Pacific region, which has 62% of all estimated TB patients globally, will require innovation, rigorous research, and sustained investment. This special issue connects original research and viewpoints on pertinent approaches for improving TB care and prevention in the Asia-Pacific region. |
| Titolo autorizzato: | Innovation and Evidence for Achieving TB Elimination in the Asia-Pacific Region ![]() |
| Formato: | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910557609703321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |